1. Home
  2. ETNB vs HLX Comparison

ETNB vs HLX Comparison

Compare ETNB & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • HLX
  • Stock Information
  • Founded
  • ETNB 2018
  • HLX 1979
  • Country
  • ETNB United States
  • HLX United States
  • Employees
  • ETNB N/A
  • HLX N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • HLX Oilfield Services/Equipment
  • Sector
  • ETNB Health Care
  • HLX Energy
  • Exchange
  • ETNB Nasdaq
  • HLX Nasdaq
  • Market Cap
  • ETNB 1.2B
  • HLX 1.4B
  • IPO Year
  • ETNB 2019
  • HLX 1997
  • Fundamental
  • Price
  • ETNB $7.34
  • HLX $8.32
  • Analyst Decision
  • ETNB Strong Buy
  • HLX Strong Buy
  • Analyst Count
  • ETNB 10
  • HLX 3
  • Target Price
  • ETNB $27.56
  • HLX $14.50
  • AVG Volume (30 Days)
  • ETNB 2.1M
  • HLX 2.2M
  • Earning Date
  • ETNB 05-08-2025
  • HLX 04-23-2025
  • Dividend Yield
  • ETNB N/A
  • HLX N/A
  • EPS Growth
  • ETNB N/A
  • HLX N/A
  • EPS
  • ETNB N/A
  • HLX 0.36
  • Revenue
  • ETNB N/A
  • HLX $1,358,560,000.00
  • Revenue This Year
  • ETNB N/A
  • HLX $5.70
  • Revenue Next Year
  • ETNB N/A
  • HLX $4.53
  • P/E Ratio
  • ETNB N/A
  • HLX $23.35
  • Revenue Growth
  • ETNB N/A
  • HLX 5.34
  • 52 Week Low
  • ETNB $5.99
  • HLX $7.56
  • 52 Week High
  • ETNB $11.84
  • HLX $13.05
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 39.62
  • HLX 49.12
  • Support Level
  • ETNB $7.66
  • HLX $8.48
  • Resistance Level
  • ETNB $9.32
  • HLX $8.90
  • Average True Range (ATR)
  • ETNB 0.77
  • HLX 0.28
  • MACD
  • ETNB -0.04
  • HLX 0.03
  • Stochastic Oscillator
  • ETNB 9.04
  • HLX 45.28

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments Well Intervention, Robotics, Production Facilities and Shallow Water Abandonment. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the US.

Share on Social Networks: